Medical Properties Trust Q3 revenue rises

By Reuters News


Overview

  • U.S. hospital real estate trust's Q3 revenue missed analyst expectations, but rose yr/yr

  • Net income for Q3 returned to profit from loss in prior year

  • Company completed asset sales and debt refinancing, generating $680 mln in proceeds and gains


Outlook

  • Company expects portfolio cash rents above $1.0 bln in 2027

  • Company outlook assumes conservative estimates for rental income from challenged tenants such as HSA

  • Company says it is focused on further debt reduction and selective growth opportunities


Result Drivers

  • ASSET SALES - Co said asset sales in Q3 generated $680 mln in proceeds and $158 mln in gains

  • DEBT REFINANCING - Co said refinancing of debt via secured notes offering resulted in $70 mln gain

  • TENANT PAYMENT ISSUES - Co said missed rent payment from HSA reduced NFFO by two cents in Q3


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Miss

$250.14 mln

$257.98 mln (6 Analysts)

Q3 Net Income

$202.08 mln


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and 2 "sell" or "strong sell"

  • The average consensus recommendation for the specialized reits peer group is "buy."

  • Wall Street's median 12-month price target for Medical Properties Trust, Inc. is $5.00, about 81.8% above its October 28 closing price of $2.75


Reuters Recommended Reads

  • Oct 26 - Alexandria Real Estate Q3 net loss widens on impairments

  • Oct 27 - Universal Health Realty Income Trust Q3 profit rises, helped by lower interest costs

  • Oct 27 - WP Carey Q3 revenue beats estimates, raises annual AFFO forecast on strong investment activity


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk